ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

ネダプラチン

Nedaplatin (Aqupla)

HCID 78357779
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
95734-82-0
標準SMILES
N.N.O=C([O-])C[O-].[Pt+2]
InChIKey
GYAVMUDJCHAASE-UHFFFAOYSA-M
分子式
C2H8N2O3Pt
平均分子量
303.18 g/mol
単同位体質量
303.018286

概要

Nedaplatin is a second generation platinum analog. It is less nephrotoxic than [DB00515] but has proven equally effective. It was approved for use in Japan in 1995.

名称と識別子

優先名称
Nedaplatin (Aqupla)
IUPAC
azane;2-oxidoacetate;platinum(2+)
現地名
ネダプラチン
英語名
Nedaplatin
分子式
C2H6N2O3Pt
分子量
301.17

名称と別名

Nedaplatin (Aqupla)ネダプラチンネダプラチン (JAN)cis-ジアンミングリコラト白金254-sAquplaNedaplaitNEDAPLATINNidaplatinNSC 375101DNedaplatin, >=99%Nedaplatin USP/EP/BP
名称をさらに表示
Nedaplatin (NSC 375101D)cis-diammine(glycolato)platinum(ii)

データベース識別子

CAS
95734-82-0
PubChem CID
78357779

物性

構造計算による物性

極性表面積
65.2 Ų
水素結合供与体数
2
水素結合受容体数
5
回転可能結合数
0
重原子数
8
形式電荷
0
複雑度
44.1

物理化学的性質

貯蔵温度
-20 °C · Inert atmosphere,Store in freezer, under -20°C
溶解性
2 O · H2O : 13.6 mg/mL (44.86 mM; Need ultrasonic and warming; DMSO can inactivate Nedaplatin's activity)DMF : < 1 mg/mL (insoluble; DMSO can inactivate Nedaplatin's activity)
外見
Powder
色
Light yellow to yellow
InChI
InChI=1S/C2H3O3.2H2N.Pt/c3-1-2(4)5;;;/h1H2,(H,4,5);2*1H2;/q3*-1;+4/p-1
InChIKey
GRHLMSBCOPRFNA-UHFFFAOYSA-M
SMILES
N[Pt+2]1([O-]CC(=O)[O-]1)N

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
WGK 3
Hazard Classifications
Acute Tox. 2 OralCarc. 1BEye Irrit. 2Resp. Sens. 1BSkin Irrit. 2Skin Sens. 1BSTOT SE 3
ストレージクラス
6.1A - Combustible acute toxic Cat. 1 and 2very toxic hazardous materials

化学と産業

薬理情報

Protein BindingApproximately 50% of the platinum from nedaplatin appears to be bound to human plasma proteins.
PharmacodynamicsNedaplatin damages DNA and induces cell death in cancer cells. It also functions as a radiosensitizer, increasing the susceptibility of the affected cells to radiation therapy.
Mechanism of Action · 1 件

As a platinum analog, nedaplatin likely works similarly to [DB00515] on which the following mechanistic description is based. Once it has entered the cell it is hydrolyzed to its active form which complexes with water molecules. This form binds to to nucleophiles in the cytoplasm such as glutathione and other cyteine rich proteins resulting in an overall increase in oxidative stress as the cell loses antioxidant proteins. It also binds to purine nucleotides in the DNA. The active form allows for two binding interactions to form cross-links between these nucleotides. High mobility group proteins-1 and -2 induce apoptosis in response to guanine cross-links and their binding serves to shield the cross-linked DNA from repair mechanisms. The mismatch repair (MMR) protein complex also recognizes the distortion caused by platinum complexes and attempts to repair the DNA. This results in single strand breaks when the MMR complex attempts to remove the platinum cross-link. The MMR complex induces apoptosis after the repair attempt has failed. The single strand break in DNA makes it easier to form lethal double strand breaks with radiation treatment thus creating the radiosensitizing effect of nedaplatin.

Absorption, Distribution and Excretion · 3 件

Most of the platinum from nedaplatin is eliminated in the urine (59.6%).

The volume of distribution of free platinum is 12.0 L.

Clearance of the free platinum is 4.47 L/h.

応用分野 · 3 件

用途DNA 鎖内及び鎖間で DNA 架 橋を形成し、DNA の複製及び転写阻害作用を 示します。

説明Nedaplatin, a novel second generation platinum complex, was marketed in Japan for the treatment of a variety of cancers including: head and neck, small-cell and non-small cell lung, oesophageal, prostatic, testicular, ovarian, cervical, bladder, and uterine cancers. Platinum anticancer agents, prototyped by cisplatin, have been reported to be hydrolyzed to the mono- or diaquated species of diamine platinum which react with nucleophilic sites on DNA to cause intrastrand and interstrand crosslinks and DNA-protein crosslinks, which result in cytotoxicity. Nedaplatin was reportedly more active than cisplatin against several solid tumors while sharing less nephro- and gastrointestinal toxicity to cisplatin in viva The minimal renal toxicity displayed by nedaplatin allows its use in patients with deteriorated renal function.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

使用Nedaplatin is a platinum complex that has potent antineoplatic activity.

サプライヤー100 社

上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
湖北万得化工有限公司15377098680 15377098680 · [email protected]
合肥翰刚医药科技有限公司+8618062405514 · [email protected]
上海遐瑞医药科技有限公司+86-021-61551413 · [email protected]
Baoji Guokang Healthchem co.,ltd+8615604608665 15604608665 · [email protected]
LGM Pharma1-(800)-881-8210 · [email protected]
江西瑞威尔生物科技有限公司400-880-2824 18107960669 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
武汉凯威斯科技有限公司86-027-67849912 · [email protected]
上海瀚鸿科技股份有限公司021-54306202 13764082696 · [email protected]
上海泰坦科技股份有限公司4006009262 13023226327 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
武汉丰泰威远科技有限公司+86-27-8746-5837 +86-18627785180 · [email protected]
上海攀鸿化工科技有限公司021-56491756 13512199871 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
贵州迪大科技有限责任公司0851-8475-2296 18096062265 · [email protected]
孝感深远化工有限公司15527621225; 15527621225 · [email protected]
武汉海正工贸发展有限公司027-8866 0053/88660577/88660578
Wuhan NCE Biomedical Co.,Ltd.4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
深圳振强药物研发有限公司0755-66853366 13670046396 · [email protected]
上海诺宝化工有限公司+86(0)21 60484900
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
南京生利德生物科技有限公司025-57798810 18652991625 · [email protected]
上海陶素生化科技有限公司021-33632979 · [email protected]
湖北威德利化学试剂有限公司186-02735115 18602735115 · [email protected]
湖北鑫源顺医药化工有限公司13971561712, 13995564702, 027-50664929 · [email protected]
上海湄水化工科技有限公司021-60549325 18616193163
上海将来实业股份有限公司021-61552785 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]
郑州鸿晟医药科技有限公司0371-0371-13526885213 15637198702 · [email protected]
四川省维克奇生物科技有限公司028-81700200 18116577057 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
上海寰川实业有限公司021-61478794 · [email protected]
广州市慈铭生物科技有限公司020-38082199,29065168,38082986,29878298,29866629,4000192398
湖北巨胜科技有限公司027-59599241 18871490274 · [email protected]
桦特昇生物科技(武汉)有限公司027-59207879 1972026995 18140587686 · [email protected]
上海泽涵生物医药科技有限公司021-61350663 13052117465 · [email protected]
南京伶亚生物医药科技有限公司18068075658 · [email protected]
TargetMol中国(陶术生物)021-021-33632979 15002134094 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
上海皓之翔生物科技有限公司(原上海拓青化工有限公司)526763801 13301653310 · [email protected]
湖北威德利化学科技有限公司027-83989310 18627915365 · [email protected]
湖北威德利化学试剂有限公司18327179646 · [email protected]
湖北玖丰隆化工有限公司13277936479 · [email protected]
湖北源梦生物科技有限公司027-68897569 18120462897 · [email protected]
武汉多普乐生物医药有限公司+86-02787215551 19945035818 · [email protected]
上海珞珐生化科技有限公司021-51111890 15317326293 · [email protected]
南京海润医药有限公司025-85090179 · [email protected]